[Experience with heterotopic heart transplantation in patients with elevated pulmonary vascular resistance: late follow-up].

BACKGROUND Along the past few years the number of papers on heterotopic cardiac transplant has been very scarce in the medical literature, including at the international level; this is particularly true in reference to the long term follow-up of these patients and the reason which led to the presentation of our report. OBJECTIVE To report the initial clinical experience and late evolution of 4 patients undergoing heterotopic heart transplantation, indications for this procedure and its major complications. METHODS The surgeries were performed between 1992 and 2001, and all had as indication for heterotopic transplantation the PVR, which ranged from 4.8 WU to 6.5 WU, with a transpulmonary gradient above 15 mmHg. In the 3rd patient, a direct anastomosis between the pulmonary arteries was performed without the use of a prostetic tube, and a mitral valvuloplasty and a LV aneurysmectomy were performed in the native heart. The immediate immunosuppressive regimens were double, with cyclosporine and azathioprine in the first 3 patients, and cyclosporine and mycophenolate mofetil in the 4th patient. RESULTS One immediate death occurred from graft failure, one death occurred after 2 (1/2) years, from endocarditis in an intraventricular thrombus in the native heart, and a third death occurred 6 years after transplantation, from post-operative complications of the aortic valve surgery in the native heart. The remaining patient is well, 15 years after the transplantation. This patient is in functional class II (NYHA), 6 years after a surgical occlusion of the native heart aortic valve. CONCLUSION Heterotopic heart transplantation results are inferior to those of orthotopic heart transplantation because they present higher RVP. The intraventricular thrombi, in the native heart, which require prolonged anticoagulation, and aortic valve complications, also in the native heart, may require surgical treatment. However, a patient's 15-year survival has demonstrated a long-term effectiveness of this option for selected patients.

[1]  F. Pagani,et al.  Heart and Lung Transplantation in the United States, 1997–2006 , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  D. Esmore,et al.  Demonstrating time sequence and extent of sustained decrease in native heart ejection fraction after heterotopic transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  B. Griffith,et al.  Clinical trial of tacrolimus versus cyclosporine in lung transplantation. , 1995, The Annals of thoracic surgery.

[4]  A. Khaghani,et al.  Effects of paced counterpulsation on exercise capacity and hemodynamics after heterotopic heart transplantation. , 1995, The American journal of cardiology.

[5]  A. Khaghani,et al.  Hemodynamic and metabolic effects of paced linkage following heterotopic cardiac transplantation. , 1994, Circulation.

[6]  M. M. Cascudo,et al.  Heterotopic heart transplantation: a direct pulmonary artery anastomosis technique. , 1994, The Journal of thoracic and cardiovascular surgery.

[7]  P. A. Saraiva,et al.  Heart and unilateral lung transplantation for cardiomyopathy with high pulmonary vascular resistance. , 1992, The Annals of thoracic surgery.

[8]  M. Yacoub,et al.  Continuous aortic regurgitation in severely dysfunctional native hearts after heterotopic cardiac transplantation. , 1989, The American journal of cardiology.

[9]  E. Blackstone,et al.  Pulmonary vascular resistance and the risk of heart transplantation. , 1988, The Journal of heart transplantation.

[10]  Kaye Mp,et al.  The Registry of the International Society for Heart Transplantation: fourth official report--1987. , 1987, Clinical transplants.

[11]  D. Novitzky,et al.  The surgical technique of heterotopic heart transplantation. , 1983, The Annals of thoracic surgery.

[12]  J. Losman,et al.  Heterotopic heart transplantation: a valid alternative to orthotopic transplantation: results, advantages, and disadvantages. , 1982, The Journal of surgical research.

[13]  S. Hunt,et al.  Cardiovascular physiology in a case of heterotopic cardiac transplantation. , 1982, The American journal of cardiology.

[14]  B. Gersh,et al.  Left ventricular bypass using a cardiac allograft: hemodynamic studies. , 1976, The American journal of cardiology.

[15]  Barnard Cn,et al.  Left ventricular bypass. , 1975 .

[16]  Barnard Cn The present status of heart transplantation. , 1975 .

[17]  E. Stinson,et al.  Determinants of operative risk in human heart transplantation. , 1971, American journal of surgery.

[18]  J. Odell,et al.  Heterotopic heart transplantation: mid-term hemodynamic and echocardiographic analysis--the concern of arteriovenous-valve incompetence. , 1990, The Journal of heart transplantation.

[19]  Kaye Mp,et al.  The Registry of the International Society for Heart Transplantation: sixth official report--1989. , 1989, The Journal of heart transplantation.

[20]  M. Kaye The Registry of the International Society for Heart Transplantation: fourth official report--1987. , 1987, The Journal of heart transplantation.

[21]  C. Barnard The present status of heart transplantation. , 1975, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.